Shattuck Labs (STTK) Competitors $1.11 +0.02 (+1.83%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends STTK vs. LRMR, SOPH, FULC, ACB, FDMT, OCGN, AMLX, DSGN, SLRN, and MOLNShould you be buying Shattuck Labs stock or one of its competitors? The main competitors of Shattuck Labs include Larimar Therapeutics (LRMR), SOPHiA GENETICS (SOPH), Fulcrum Therapeutics (FULC), Aurora Cannabis (ACB), 4D Molecular Therapeutics (FDMT), Ocugen (OCGN), Amylyx Pharmaceuticals (AMLX), Design Therapeutics (DSGN), Acelyrin (SLRN), and Molecular Partners (MOLN). These companies are all part of the "pharmaceutical products" industry. Shattuck Labs vs. Larimar Therapeutics SOPHiA GENETICS Fulcrum Therapeutics Aurora Cannabis 4D Molecular Therapeutics Ocugen Amylyx Pharmaceuticals Design Therapeutics Acelyrin Molecular Partners Shattuck Labs (NASDAQ:STTK) and Larimar Therapeutics (NASDAQ:LRMR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, risk and dividends. Do institutionals & insiders believe in STTK or LRMR? 58.7% of Shattuck Labs shares are held by institutional investors. Comparatively, 91.9% of Larimar Therapeutics shares are held by institutional investors. 10.5% of Shattuck Labs shares are held by company insiders. Comparatively, 3.5% of Larimar Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is STTK or LRMR more profitable? Larimar Therapeutics has a net margin of 0.00% compared to Shattuck Labs' net margin of -1,156.46%. Larimar Therapeutics' return on equity of -35.87% beat Shattuck Labs' return on equity.Company Net Margins Return on Equity Return on Assets Shattuck Labs-1,156.46% -61.92% -54.49% Larimar Therapeutics N/A -35.87%-32.37% Which has more risk and volatility, STTK or LRMR? Shattuck Labs has a beta of 1.71, meaning that its share price is 71% more volatile than the S&P 500. Comparatively, Larimar Therapeutics has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Does the MarketBeat Community believe in STTK or LRMR? Larimar Therapeutics received 3 more outperform votes than Shattuck Labs when rated by MarketBeat users. However, 71.15% of users gave Shattuck Labs an outperform vote while only 68.97% of users gave Larimar Therapeutics an outperform vote. CompanyUnderperformOutperformShattuck LabsOutperform Votes3771.15% Underperform Votes1528.85% Larimar TherapeuticsOutperform Votes4068.97% Underperform Votes1831.03% Do analysts recommend STTK or LRMR? Shattuck Labs currently has a consensus target price of $8.67, suggesting a potential upside of 680.78%. Larimar Therapeutics has a consensus target price of $20.43, suggesting a potential upside of 511.63%. Given Shattuck Labs' higher possible upside, equities analysts plainly believe Shattuck Labs is more favorable than Larimar Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shattuck Labs 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.40Larimar Therapeutics 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Which has higher earnings and valuation, STTK or LRMR? Larimar Therapeutics has lower revenue, but higher earnings than Shattuck Labs. Larimar Therapeutics is trading at a lower price-to-earnings ratio than Shattuck Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShattuck Labs$1.66M31.92-$87.30M-$1.53-0.73Larimar TherapeuticsN/AN/A-$36.95M-$1.15-2.90 Does the media refer more to STTK or LRMR? In the previous week, Shattuck Labs' average media sentiment score of 0.00 equaled Larimar Therapeutics'average media sentiment score. Company Overall Sentiment Shattuck Labs Neutral Larimar Therapeutics Neutral SummaryLarimar Therapeutics beats Shattuck Labs on 9 of the 15 factors compared between the two stocks. Get Shattuck Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for STTK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STTK vs. The Competition Export to ExcelMetricShattuck LabsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$52.99M$6.52B$5.34B$9.11BDividend YieldN/A2.95%5.37%4.00%P/E Ratio-0.734.2756.8413.06Price / Sales31.92310.261,275.3476.04Price / CashN/A22.6336.6132.89Price / Book0.334.964.874.58Net Income-$87.30M$154.90M$118.05M$224.84M7 Day Performance-0.89%1.35%1.47%2.37%1 Month Performance-3.48%0.41%2.54%4.40%1 Year Performance-87.69%3.08%25.37%20.10% Shattuck Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STTKShattuck Labs2.4302 of 5 stars$1.11+1.8%$8.67+680.8%-87.7%$52.99M$1.66M-0.73100LRMRLarimar Therapeutics1.3894 of 5 stars$3.50-4.4%$20.43+483.7%-22.0%$223.32MN/A-3.0430Gap UpSOPHSOPHiA GENETICS2.96 of 5 stars$3.40+17.6%$7.40+117.6%-30.7%$222.28M$64.49M-3.12520News CoveragePositive NewsFULCFulcrum Therapeutics2.0338 of 5 stars$4.12-5.7%$9.33+126.5%-42.8%$222.23M$80.87M-13.29100Positive NewsACBAurora Cannabis0.213 of 5 stars$4.04-2.2%N/A-6.4%$221.70M$296.99M-5.321,073Short Interest ↑FDMT4D Molecular Therapeutics3.4754 of 5 stars$4.78-13.4%$38.56+706.6%-73.1%$220.97M$17,000.00-1.68120Analyst ForecastOCGNOcugen2.151 of 5 stars$0.75-4.5%$5.67+654.2%+38.7%$218.87M$4.70M-4.1780AMLXAmylyx Pharmaceuticals3.1603 of 5 stars$3.19-8.9%$7.33+129.9%-76.0%$218.67M$196.49M-0.84200DSGNDesign Therapeutics1.7437 of 5 stars$3.86-14.6%$7.00+81.3%+116.2%$218.55MN/A-4.5440Short Interest ↑News CoverageSLRNAcelyrin2.9864 of 5 stars$2.14+3.9%$9.60+348.6%-66.3%$214.70MN/A-0.87135Positive NewsMOLNMolecular Partners0.1987 of 5 stars$5.30+6.4%N/A+17.4%$213.92M$6.00M-2.47180Gap Down Related Companies and Tools Related Companies Larimar Therapeutics Competitors SOPHiA GENETICS Competitors Fulcrum Therapeutics Competitors Aurora Cannabis Competitors 4D Molecular Therapeutics Competitors Ocugen Competitors Amylyx Pharmaceuticals Competitors Design Therapeutics Competitors Acelyrin Competitors Molecular Partners Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:STTK) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shattuck Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shattuck Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STTK Stock Alerts